CT Coya Therapeutics, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Track the Coya Therapeutics, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €98.3m. The latest transaction was reported on 19 August 2025 (Levée d'options). Among the most active insiders: GOLDSTEIN DOV A MD. Every trade is openly available.
€103,122
12 ops.
Buy Volume
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 August 2025
All Executives13 Thresholds0 Prospectus0 Other0
Declarations 13 total
◇ Director · Executives · 18 Aug 2025
17,557 shares @ US$1.09 100.0% of flow Common Stock, par value $0.0001 per share SEC:0001641172-25-024820:0
▲ Chief Financial Officer · Executives · 14 Nov 2024
1,800 shares @ US$7.1858 100.0% of flow Common Stock, par value $0.0001 per share SEC:0001493152-24-046106:0
Canonical exit: 12 Feb 2025 (T+90) ▲ Chief Executive Officer · Executives · 13 Nov 2024
5,000 shares @ US$7.3594 50.3% of flow Common Stock, par value $0.0001 per share SEC:0001493152-24-045120:0
Canonical exit: 11 Feb 2025 (T+90) ▲ Chief Executive Officer · Executives · 11 Nov 2024
5,000 shares @ US$7.3378 49.7% of flow Common Stock, par value $0.0001 per share SEC:0001493152-24-044819:0
Canonical exit: 9 Feb 2025 (T+90) ▲ Chief Medical Officer · Executives · 11 Nov 2024
2,710 shares @ US$7.37 100.0% of flow Common Stock, par value $0.0001 per share SEC:0001493152-24-044896:0
Canonical exit: 9 Feb 2025 (T+90) ▲ Director · Executives · 22 Aug 2023
1,000 shares @ US$3.62 100.0% of flow Common Stock, par value $0.0001 per share SEC:0001493152-24-008916:0
Canonical exit: 20 Nov 2023 (T+90) ▲ Director · Executives · 3 Jan 2023
2,000 shares Common Stock, par value $0.0001 per share SEC:0001493152-23-000223:0
Canonical exit: 3 Apr 2023 (T+90) ▲ Director · Executives · 3 Jan 2023
10,000 shares Common Stock, par value $0.0001 per share SEC:0001493152-23-000221:0
Canonical exit: 3 Apr 2023 (T+90) ▲ Director · Executives · 3 Jan 2023
10,000 shares Common Stock, par value $0.0001 per share SEC:0001493152-23-000222:0
Canonical exit: 3 Apr 2023 (T+90) ▲ Chief Financial Officer · Executives · 3 Jan 2023
7,000 shares Common Stock, par value $0.0001 per share SEC:0001493152-23-000224:0
Canonical exit: 3 Apr 2023 (T+90) ▲ Chief Executive Officer · Executives · 3 Jan 2023
10,000 shares Common Stock, par value $0.0001 per share SEC:0001493152-23-000227:0
Canonical exit: 3 Apr 2023 (T+90) ▲ Director · Executives · 3 Jan 2023
10,000 shares Common Stock, par value $0.0001 per share SEC:0001493152-23-000226:0
Canonical exit: 3 Apr 2023 (T+90) ▲ Chief Medical Officer · Executives · 3 Jan 2023
10,000 shares Common Stock, par value $0.0001 per share SEC:0001493152-23-000225:0
Canonical exit: 3 Apr 2023 (T+90) 关于 Coya Therapeutics, Inc. Coya Therapeutics, Inc. 是一家生物制药公司，专注于开发神经退行性疾病的创新疗法。该公司致力于研究和商业化能够提高患者生活质量的治疗方法。